iTonic Holdings Ltd.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $5.5M
- Price
- $0.32
- % Change (Daily % change from the live per-ticker quote feed.)
- +2.49%
- Volume
- 23.3K
Quote data as of 6:11 AM ET
About
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.
Quick stats
Shares outstanding17.1M
Computed float9.3M
Float sourceUnknown
Cash runway (months)Unknown
Dilution risk—
Has warrants—
Has convertibles—
Active shelf (Shelf registration (e.g. Form S-3) currently in effect — the company is pre-cleared to issue and sell new shares quickly. A standing dilution risk.)—
Active ATM (At-the-market offering — a program to sell newly issued shares directly into the open market at prevailing prices, diluting existing holders over time.)—
Key info
SectorHealthcare
IndustryMedical - Specialties
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001970544
Websitehttp://www.ftzy.com.cn
AI Summary
AI-generated3mo agostandardneutralregulatoryiTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule
Nasdaq granted iTonic Holdings a 180-day extension, until October 19, 2026, to regain compliance with the minimum bid price requirement.
The extension follows the expiration of the initial 180-day compliance period on April 20, 2026.
Failure to regain compliance by the new deadline will result in delisting, though the company may appeal to a Hearings Panel.
Red flags
- Company received extension because it failed to meet minimum bid price requirement within initial 180-day period
- Failure to regain compliance by October 19, 2026, will result in delisting of Class A ordinary shares